VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NRIX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NRIXNurix Therapeutics, Inc.
$23.85$2.1B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNRIXQuarterly Financials

Nurix Therapeutics, Inc. (NRIX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Nurix Therapeutics, Inc. (NRIX) quarterly income statement — complete revenue, gross profit & net income history

NRIX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue6.25M13.58M7.89M44.06M18.45M13.28M12.59M12.09M16.59M15.16M18.47M30.68M12.69M6.78M10.79M11.43M9.62M7.4M10.25M7.09M
Revenue Growth %-66.12%2.21%-37.29%264.34%11.26%-12.37%-31.84%-60.58%30.75%123.49%71.13%168.33%31.85%-8.29%5.26%61.22%92%10.57%150.97%69.56%
Cost of Goods Sold84.14M4.63M5M78.1M69.66M67.22M55.48M48.92M50.01M49.71M47.86M45.76M45.82M46.11M47.76M47.49M43.14M36.53M30.91M25.99M
COGS % of Revenue1345.76%34.11%63.34%177.27%377.52%506.05%440.75%404.58%301.51%327.94%259.14%149.18%361.18%679.73%442.6%415.44%448.36%493.93%301.46%366.58%
Gross Profit-77.89M8.95M2.89M-34.04M-51.21M-53.94M-42.89M-36.83M-33.42M-34.55M-29.39M-15.09M-33.13M-39.32M-36.97M-36.06M-33.52M-29.14M-20.65M-18.9M
Gross Margin %-1245.76%65.89%36.66%-77.27%-277.52%-406.05%-340.75%-304.58%-201.51%-227.94%-159.14%-49.18%-261.18%-579.73%-342.6%-315.44%-348.36%-393.93%-201.46%-266.58%
Gross Profit Growth %-52.09%116.59%106.75%7.58%-53.23%-56.1%-45.95%-144.12%-0.87%12.13%20.51%58.16%1.15%-34.97%-79%-90.77%-86.28%-111.8%-39.05%-89.79%
Operating Expenses14.61M92.04M94.28M14.28M11.65M10.72M11.72M11.71M11.8M10.78M10.62M11.68M9.82M9.37M9.75M9.65M9.23M8.82M8.34M7.51M
OpEx % of Revenue233.69%677.92%1194.31%32.42%63.15%80.68%93.09%96.84%71.14%71.11%57.52%38.07%77.42%138.1%90.33%84.45%95.92%119.23%81.38%105.92%
Selling, General & Admin14.61M13.65M13.16M14.28M11.65M10.72M11.72M11.71M11.8M10.78M10.62M11.68M9.82M9.37M9.75M9.65M9.23M8.82M8.34M7.51M
SG&A % of Revenue233.69%100.52%166.7%32.42%63.15%80.68%93.09%96.84%71.14%71.11%57.52%38.07%77.42%138.1%90.33%84.45%95.92%119.23%81.38%105.92%
Research & Development080.9M86.12M78.1M69.66M67.22M55.48M48.92M50.01M49.71M47.86M45.76M45.82M46.11M47.76M47.49M43.14M36.53M30.91M25.99M
R&D % of Revenue-595.89%1090.96%177.27%377.52%506.05%440.75%404.58%301.51%327.94%259.14%149.18%361.18%679.73%442.6%415.44%448.36%493.93%301.46%366.58%
Other Operating Expenses0-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K-1000K
Operating Income-92.5M-83.09M-91.39M-48.32M-62.86M-64.66M-54.61M-48.54M-45.22M-45.33M-40.01M-26.77M-42.95M-48.69M-46.72M-45.72M-42.74M-37.95M-29M-26.41M
Operating Margin %-1479.45%-612.03%-1157.65%-109.68%-340.67%-486.73%-433.83%-401.42%-272.65%-299.06%-216.67%-87.25%-338.6%-717.82%-432.93%-399.89%-444.28%-513.16%-282.84%-372.5%
Operating Income Growth %-47.14%-28.52%-67.34%0.45%-39.02%-42.62%-36.49%-81.36%-5.28%6.89%14.35%41.45%-0.49%-28.29%-61.11%-73.07%-74.31%-89.69%-51.09%-99.65%
EBITDA-88.72M-73.83M-86.39M-46.08M-60.51M-63.41M-52.22M-46.21M-43.17M-44.8M-38.06M-24.87M-41.2M-48.27M-45.26M-44.43M-41.75M-37.2M-28.25M-25.77M
EBITDA Margin %-1419.05%-543.79%-1094.31%-104.59%-327.94%-477.33%-414.82%-382.15%-260.32%-295.53%-206.1%-81.07%-324.79%-711.65%-419.43%-388.67%-433.98%-502.92%-275.58%-363.4%
EBITDA Growth %-46.61%-16.44%-65.43%0.28%-40.16%-41.54%-37.19%-85.81%-4.79%7.19%15.91%44.03%1.32%-29.77%-60.2%-72.43%-74.85%-92.09%-51.55%-102.35%
D&A (Non-Cash Add-back)3.78M9.26M5M2.24M2.35M1.25M2.39M2.33M2.04M534K1.95M1.9M1.75M419K1.46M1.28M991K757K745K645K
EBIT-87.17M-78.22M-86.42M-42.7M-56.35M-58.54M-48.87M-44.46M-41.43M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.66M-28.96M-26.41M
Net Interest Income5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K39K171K
Interest Income5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K39K171K
Interest Expense00000000000000000000
Other Income/Expense5.32M4.87M4.96M5.62M6.51M6.12M5.74M4.08M3.79M3.38M3.03M2.49M2.22M1.97M1.01M314K211K295K39K171K
Pretax Income-87.17M-78.22M-86.42M-42.7M-56.35M-58.54M-48.87M-44.46M-41.43M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.66M-28.96M-26.24M
Pretax Margin %-1394.34%-576.13%-1094.77%-96.93%-305.38%-440.69%-388.26%-367.65%-249.79%-276.77%-200.26%-79.14%-321.11%-688.74%-423.58%-397.14%-442.08%-509.17%-282.46%-370.09%
Income Tax000760K08K82K90K90K0000000044K-123K139K
Effective Tax Rate %0%0%0%-1.78%0%-0.01%-0.17%-0.2%-0.22%0%0%0%0%0%0%0%0%-0.12%0.42%-0.53%
Net Income-87.17M-78.22M-86.42M-43.46M-56.35M-58.55M-48.96M-44.55M-41.52M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.7M-28.84M-26.38M
Net Margin %-1394.34%-576.13%-1094.77%-98.66%-305.38%-440.75%-388.91%-368.39%-250.33%-276.77%-200.26%-79.14%-321.11%-688.74%-423.58%-397.14%-442.08%-509.76%-281.26%-372.05%
Net Income Growth %-54.7%-33.6%-76.53%2.43%-35.73%-39.55%-32.38%-83.49%-1.93%10.19%19.09%46.53%4.23%-23.91%-58.52%-72.09%-75.21%-89.32%-55.72%-448.05%
Net Income (Continuing)-87.17M-78.22M-86.42M-43.46M-56.35M-58.55M-48.96M-44.55M-41.52M-41.96M-36.98M-24.28M-40.73M-46.72M-45.71M-45.4M-42.53M-37.7M-28.84M-26.38M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.79-0.82-1.03-0.52-0.67-0.75-0.67-0.71-0.76-0.77-0.68-0.40-0.65-0.77-0.88-1.00-0.95-0.85-0.65-0.60
EPS Growth %-17.91%-9.33%-53.73%26.76%11.84%2.6%1.47%-77.5%-16.92%0%22.73%60%31.58%9.41%-35.38%-66.67%-50.79%-66.67%40.37%-372.73%
EPS (Basic)-0.79-0.82-1.03-0.52-0.67-0.75-0.67-0.71-0.76-0.77-0.68-0.40-0.65-0.77-0.88-1.00-0.95-0.85-0.65-0.60
Diluted Shares Outstanding110.07M95.09M84.16M83.88M83.56M78.41M72.78M62.38M54.9M54.67M54.39M54.26M54.03M53.94M50.87M44.9M44.69M44.55M44.37M43.8M
Basic Shares Outstanding110.07M95.09M84.16M83.88M83.56M78.41M72.78M62.38M54.9M54.67M54.39M54.26M54.03M53.94M50.87M44.9M44.69M44.55M44.37M43.8M
Dividend Payout Ratio--------------------